Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 6
Submit an article Journal homepage
869
Views
63
CrossRef citations to date
0
Altmetric
Original Article

Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study

S.R. AravindDiacon Hospital, Bangalore, IndiaCorrespondence[email protected]
,
Khaled Al TayebKing Abdullah Medical City Al-Noor Hospital, Makkah, Saudi Arabia
,
Shaiful Bahari IsmailHospital Universiti Sains Malaysia, Kelantan, Malaysia
,
Naim ShehadehMeyer – Children’s Hospital of Haifa, Haifa, Israel
,
Ghaida KaddahaRashid Hospital, Dubai, United Arab Emirates
,
Rose LiuSyreon Corporation, Vancouver, BC Canada
,
Robert BalshawSyreon Corporation, Vancouver, BC Canada
,
Nadia LesnikovaSyreon Corporation, Vancouver, BC Canada
,
Olaf HeiselSyreon Corporation, Vancouver, BC Canada
,
Cynthia J. GirmanMerck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
,
Bret J. MusserMerck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
,
Michael J. DaviesMerck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
,
Harvey L. KatzeffMerck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
,
Samuel S. EngelMerck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
,
Larry RadicanMerck Sharp & Dohme Corp, Whitehouse Station, NJ, USA
& for the 2009 Ramadan Study Group show all
Pages 1237-1242 | Accepted 02 Apr 2011, Published online: 20 Apr 2011

Citations (63)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Luigi Barrea, Claudia Vetrani, Massimiliano Caprio, Marwan El Ghoch, Evelyn Frias-Toral, Rucha J. Mehta, Verna Mendez, Eleonora Moriconi, Stavroula A. Paschou, Agnieszka Pazderska, Silvia Savastano, Annamaria Colao & Giovanna Muscogiuri. (2023) Nutritional management of type 2 diabetes in subjects with obesity: an international guideline for clinical practice. Critical Reviews in Food Science and Nutrition 63:16, pages 2873-2885.
Read now
MD Faruque Pathan, Nazma Akter, Shahjada Selim, M Saifuddin, Nazmul Kabir Qureshi, ABM Kamrul-Hasan, Mohammad Abdul Hannan, Md Ashraf Uddin Ahmed, Marufa Mustari & Ashish Kumar Chakraborty. (2022) Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh. Diabetes, Metabolic Syndrome and Obesity 15, pages 4011-4021.
Read now
Ayla M Tourkmani, Mohamed Azmi Hassali, Turki J Alharbi, Hesham I Alkhashan, Aljoharah H Alobikan, Ahmed H Bakhiet, Hala B Alqahtani, Alian A Alrasheedy, Ahmed D Alawwad, Adel M Mishriky & Hisham Aljadhey. (2016) Impact of Ramadan focused education program on hypoglycemic risk and metabolic control for patients with type 2 diabetes. Patient Preference and Adherence 10, pages 1709-1717.
Read now
Ahmed AK Hassoun, Md Faruque Pathan, Rita C Medlej, Monira Alarouj, Inass Shaltout, Manoj S Chawla, Ditte Knap & Julius A Vaz. (2016) Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study. Diabetes, Metabolic Syndrome and Obesity 9, pages 225-231.
Read now
Awadhesh Kumar Singh & Ritu Singh. (2016) Is gliclazide a sulfonylurea with difference? A review in 2016. Expert Review of Clinical Pharmacology 9:6, pages 839-851.
Read now
Kamran MA Aziz. (2015) Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients. Diabetes, Metabolic Syndrome and Obesity 8, pages 207-211.
Read now
Mohamed Hassanein, Khalifa Abdallah & Anja Schweizer. (2014) A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study. Vascular Health and Risk Management 10, pages 319-326.
Read now
Anja Schweizer, Serge Halimi & Sylvie Dejager. (2014) Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan. Vascular Health and Risk Management 10, pages 15-24.
Read now
Sosale R. Aravind. (2014) Adding a DPP-4 inhibitor to metformin therapy may be safer than you think. Current Medical Research and Opinion 30:5, pages 791-794.
Read now
A.H. Barnett, R. Brice, W. Hanif, J. James & H. Langerman. (2013) Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents. Current Medical Research and Opinion 29:11, pages 1503-1513.
Read now
Mohamed A AlMaatouq. (2012) Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan. Diabetes, Metabolic Syndrome and Obesity 5, pages 109-119.
Read now
S.R. Aravind, Shaiful Bahari Ismail, R. Balamurugan, Jugal Bihari Gupta, Tarun Wadhwa, Sze Min Loh, Shailaja Suryawanshi, Michael J. Davies, Cynthia J. Girman, Harvey L. Katzeff, Larry Radican, Samuel S. Engel & Troels Wolthers. (2012) Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Current Medical Research and Opinion 28:8, pages 1289-1296.
Read now
Berit Inkster, Nicola N Zammitt & Brian M Frier. (2012) Drug-induced hypoglycaemia in type 2 diabetes. Expert Opinion on Drug Safety 11:4, pages 597-614.
Read now

Articles from other publishers (50)

Yeliz Akkuş & Serap Parlar Kiliç. (2022) Feelings, Difficulties and Attitudes in relation to Fasting: A Qualitative Study on Spiritual Coping Among Turkish Patients with Type 2 Diabetes. Journal of Religion and Health 62:6, pages 4382-4398.
Crossref
Mayada M. Samkari, Neda'a S. Bokhari, Raghad Alhajaji, Malaz E. Ahmed, Ahmad Al Raddadi, Alaa K. Bahget, Sarah F. Saleh, Faisal Aljehani, Saud H. Alzahrani, Sarah S. Alsifyani, May M. Samkari, Aisha F. Badr, Mai Alalawi & Khalid Al Sulaiman. (2023) Safety and tolerability of Empagliflozin use during the holy month of Ramadan by fasting patients with type 2 diabetes: A prospective cohort study. Saudi Pharmaceutical Journal 31:6, pages 972-978.
Crossref
Ali Tootee, Fatemeh Bandarian, Nazli Namazi, Rasha Atlasi & Bagher Larijani. (2023) Ramadan fasting and type 1 diabetes: a scoping review protocol. BMJ Open 13:3, pages e058847.
Crossref
Lobna F. El Toony, Shimaa A. Elghazally & Dina Ali Hamad. (2022) Positive impact of pre-Ramadan education on glycemic control and reducing risk of hypoglycemia in type 2 diabetic elderly patients during COVID 19 pandemic. Primary Care Diabetes 16:4, pages 581-587.
Crossref
Harpreet S. Bajaj, Lisa Chu, Nandini Bansal, Ruth E. Brown, Gagandeep Dhillon, Rishabh Gupta, Jatminderpal S. Bhela, Jagjit K. Padda, Hasnain Khandwala, Karri Venn & Ronnie Aronson. (2022) Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial. Canadian Journal of Diabetes 46:5, pages 495-502.
Crossref
Ibtissem Oueslati, Asma Kardi, Fatma Boukhayatia, Bassem Hammami, Meriem Cheikh, Neila Ben Romdhane, Moncef Feki, Meriem Yazidi & Melika Chihaoui. (2022) Impact of Ramadan intermittent fasting on metabolic and inflammatory profiles in type 2 diabetic patients. Journal of Diabetes & Metabolic Disorders 21:1, pages 751-758.
Crossref
Sumera Ahmed, Natasha Khokhar & Jay H. Shubrook. (2022) Fasting during Ramadan: A Comprehensive Review for Primary Care Providers. Diabetology 3:2, pages 276-291.
Crossref
I. V. Kononenko & O. M. Smirnova. (2021) Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies. Diabetes mellitus 24:4, pages 350-356.
Crossref
Syed Abbas Raza, Javed Akram, Azizul Hasan Aamir, Yakoob Ahmedani & Mohammad Imtiaz Hassan. (2021) Evaluation of the effectiveness and tolerability of gliclazide modified release 60 mg in patients with type 2 diabetes observing fasting during Ramadan in Pakistan: An analysis from the global DIA-RAMADAN study. Diabetes Research and Clinical Practice 181, pages 109086.
Crossref
Subhash Wangnoo, M. Shunmugavelu, Sagili Vijaya Bhaskar Reddy, Vijay Negalur, Shreerang Godbole, Vinay K Dhandhania, Nareen Krishna & Kumar Gaurav. (2021) Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India. Endocrine and Metabolic Science 4, pages 100102.
Crossref
Mohamed Hassanein, Saud Al Sifri, Shehla Shaikh, Syed Abbas Raza, Javed Akram, Achmad Rudijanto, Inass Shaltout, Md. Fariduddin, Wan Mohd Izani Bin Wan Mohamed, Fatheya Al Awadi, Alexandra Durocher, Viviana Cortese & Thamer Alessa. (2021) Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN. Diabetes Therapy 12:6, pages 1703-1719.
Crossref
Ali Tootee & Bagher Larijani. (2021) Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update. Journal of Diabetes & Metabolic Disorders 20:1, pages 1003-1009.
Crossref
Ali Tootee & Bagher Larijan. (2021) Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update. Journal of Diabetes & Metabolic Disorders 20:1, pages 1085-1091.
Crossref
Dana Abdelrahim, MoezAlIslam E. Faris, Mohamed Hassanein, Ayman Z. Shakir, Ayesha M. Yusuf, Aljohara S. Almeneessier & Ahmed S. BaHammam. (2021) Impact of Ramadan Diurnal Intermittent Fasting on Hypoglycemic Events in Patients With Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials and Observational Studies. Frontiers in Endocrinology 12.
Crossref
Abdelnaser Zalan & Rajech Sharkia. 2021. Handbook of Healthcare in the Arab World. Handbook of Healthcare in the Arab World 1101 1131 .
Syed H. Ahmed, Tahseen A. Chowdhury, Sufyan Hussain, Ateeq Syed, Ali Karamat, Ahmed Helmy, Salman Waqar, Samina Ali, Ammarah Dabhad, Susan T. Seal, Anna Hodgkinson, Shazli Azmi & Nazim Ghouri. (2020) Ramadan and Diabetes: A Narrative Review and Practice Update. Diabetes Therapy 11:11, pages 2477-2520.
Crossref
Huai Heng Loh & Nor Azmi Kamaruddin. (2020) Treatment Options for Patients with Type 2 Diabetes Mellitus during the Fasting Month of Ramadan. Annals of the Academy of Medicine, Singapore 49:7, pages 468-476.
Crossref
Dante S. Harbuwono, Farid Kurniawan, Nani C. Sudarsono & Dicky L. Tahapary. (2020) The impact of Ramadan fasting on glucose variability in type 2 diabetes mellitus patients on oral anti diabetic agents. PLOS ONE 15:6, pages e0234443.
Crossref
W. Hanif, V. Patel, S.N. Ali, A. Karamat, M. Saeed, M. Hassanein, A. Syed, T.A. Chowdhury, A. Farooqi & K. Khunti. (2020) The South Asian Health Foundation (UK) guidelines for managing diabetes during Ramadan. Diabetes Research and Clinical Practice 164, pages 108145.
Crossref
Mahmoud Ibrahim, Melanie J Davies, Ehtasham Ahmad, Firas A Annabi, Robert H Eckel, Ebtesam M Ba-Essa, Nuha Ali El Sayed, Amy Hess Fischl, Pamela Houeiss, Hinde Iraqi, Ines Khochtali, Kamlesh Khunti, Shabeen Naz Masood, Safia Mimouni-Zerguini, Samad Shera, Jaakko Tuomilehto & Guillermo E Umpierrez. (2020) Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. BMJ Open Diabetes Research & Care 8:1, pages e001248.
Crossref
Mohamed Hassanein, Saud Al Sifri, Shehla Shaikh, Syed Abbas Raza, Javed Akram, Agung Pranoto, Achmad Rudijanto, Inass Shaltout, Md Fariduddin, Wan Mohd Izani Wan Mohamed, Fatheya Al Awadi & Thamer Alessa. (2020) A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN. Diabetes Research and Clinical Practice 163, pages 108154.
Crossref
David Morris. (2020) Managing diabetes in primary care during Ramadan. Practice Nursing 31:4, pages 148-154.
Crossref
Elamin Abdelgadir, Fauzia Rashid, Alaaeldin Bashier, Maryam Al Saeed, Azza Khalifa, Fatheya Alawadi & Mohamed Hassanein. (2019) Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:5, pages 2927-2932.
Crossref
Natalia Р. Trubitsyna & Marina V. Shestakova. (2019) Review of the results of the EASYDia international observational study. The effect of dose titration of diabeton MR on the effectiveness of treatment of type 2 diabetes. Diabetes mellitus 22:2, pages 159-164.
Crossref
Mohamed Hassanein, Fatheya F. Al Awadi, Khaled El Sayed El Hadidy, Sobia Sabir Ali, Akram Echtay, Khier Djaballah, Cecile Dessapt-Baradez, Faris Abdul Kareem Khazaal, Mohamad Omar Abu-Hijleh, Abdulrahman Al Shaikh, Mohamed El Hassan Gharbi, Naim Shehadeh, Abdullah Bennakhi & Monira Al Arouj. (2019) The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM). Diabetes Research and Clinical Practice 151, pages 275-284.
Crossref
Mohamed M. Hassanein, Rakesh Sahay, Khadija Hafidh, Khier Djaballah, Haoyu Li, Sami Azar, Naim Shehadeh & Wasim Hanif. (2019) Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial. Diabetes Research and Clinical Practice 150, pages 331-341.
Crossref
Fauzia Rashid & Elamin Abdelgadir. (2019) A systematic review on efficacy and safety of the current hypoglycemic agents in patients with diabetes during Ramadan fasting. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:2, pages 1413-1429.
Crossref
Harpreet Singh Bajaj, Tyceer Abouhassan, Muhammad Rauf Ahsan, Amel Arnaout, Mohamed Hassanein, Robyn L. Houlden, Tayyab Khan, Hasnain Khandwala & Subodh Verma. (2019) Diabetes Canada Position Statement for People With Types 1 and 2 Diabetes Who Fast During Ramadan. Canadian Journal of Diabetes 43:1, pages 3-12.
Crossref
Abdelnaser Zalan & Rajech Sharkia. 2019. Handbook of Healthcare in the Arab World. Handbook of Healthcare in the Arab World 1 32 .
Lawrence A. Leiter, Marina V. Shestakova & Ilhan Satman. (2018) Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial. Diabetology & Metabolic Syndrome 10:1.
Crossref
Anoop Misra, Naveed Sattar, Nikhil Tandon, Usha Shrivastava, Naval K Vikram, Kamlesh Khunti & Andrew P Hills. (2018) Clinical management of type 2 diabetes in south Asia. The Lancet Diabetes & Endocrinology 6:12, pages 979-991.
Crossref
Tarik Elhadd, Zeinab Dabbous, Mohammed Bashir, Abdulnasir Elzouki, Wissam Ghadban, Khaled Baagar, Silas Benjamin, Mohamed Hassanien, Abazar A. M. Saeed, Khaled Dukhan, Rayaz A. Malik & Abdul-Badie Abou-Samra. (2018) Incidence of hypoglycaemia in patients with type-2 diabetes taking multiple glucose lowering therapies during Ramadan: the PROFAST Ramadan Study. Journal of Diabetes & Metabolic Disorders 17:2, pages 309-314.
Crossref
Mohammed Bashir, Tarik Elhadd, Hamda Ali, Khaled Baagar, Ibrahim A. Abdel Hakam, Dabia H.S. Al-Mohanadi, Emad Naem, Amina Al Abdulla, Kawsar Mohammed & Abdul-Badie Abou-Samra. (2018) A pilot study using flash continuous glucose monitoring in patients with type-2 diabetes on multiple anti-diabetic agents during Ramadan. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:6, pages 965-968.
Crossref
Lobna F. El Toony, Dina Ali Hamad & Omar Mohammed Omar. (2018) Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:5, pages 761-767.
Crossref
Richard Silbert, Alejandro Salcido-Montenegro, Rene Rodriguez-Gutierrez, Abdulrahman Katabi & Rozalina G. McCoy. (2018) Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies. Current Diabetes Reports 18:8.
Crossref
Shaukat Sadikot, K. Jothydev, A.H. Zargar, Jamal Ahmad, S.R. Arvind & Banshi Saboo. (2017) Clinical practice points for diabetes management during RAMADAN fast. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 11, pages S811-S819.
Crossref
Kelly Grindrod & Wasem Alsabbagh. (2017) Managing medications during Ramadan fasting. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 150:3, pages 146-149.
Crossref
Mohamed Hassanein, Monira Al-Arouj, Osama Hamdy, Wan Mohamad Wan Bebakar, Abdul Jabbar, Abdulrazzaq Al-Madani, Wasim Hanif, Nader Lessan, Abdul Basit, Khaled Tayeb, MAK Omar, Khalifa Abdallah, Abdulaziz Al Twaim, Mehmet Akif Buyukbese, Adel A. El-Sayed & Abdullah Ben-Nakhi. (2017) Diabetes and Ramadan: Practical guidelines. Diabetes Research and Clinical Practice 126, pages 303-316.
Crossref
Abdallah M. BeanoMohammad A. ZmailiZaid H. GheithAhmad M. NaserMunther S. MomaniAl-Motassem F. YousefAyman A. Zayed. (2017) Predetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety. Endocrinology and Metabolism 32:2, pages 265.
Crossref
Fatmah A.M. Al-Omary. 2017. 125 192 .
S. T. Azar, A. Echtay, W. M. Wan Bebakar, S. Al Araj, A. Berrah, M. Omar, A. Mutha, K. Tornøe, M. S. Kaltoft & N. Shehadeh. (2016) Efficacy and safety of liraglutide compared to sulphonylurea during R amadan in patients with type 2 diabetes ( LIRA‐R amadan): a randomized trial . Diabetes, Obesity and Metabolism 18:10, pages 1025-1033.
Crossref
Saud Al Sifri & Kashif Rizvi. (2016) Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence. Diabetes Therapy 7:2, pages 221-240.
Crossref
Jean Claude Mbanya, Saud Al-Sifri, Aly Abdel-Rahim & Ilhan Satman. (2015) Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach. Diabetes Research and Clinical Practice 109:2, pages 226-232.
Crossref
S. M. Babineaux, D. Toaima, K. S. Boye, A. Zagar, A. Tahbaz, A. Jabbar & M. Hassanein. (2015) Multi‐country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 ( CREED ) . Diabetic Medicine 32:6, pages 819-828.
Crossref
E. M. Brady, M. J. Davies, L. J. Gray, M. A. Saeed, D. Smith, W. Hanif & K. Khunti. (2014) A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial. Diabetes, Obesity and Metabolism 16:6, pages 527-536.
Crossref
S. Halimi & M. Lévy. (2014) Prise en charge des patients diabétiques de type 2 durant le Ramadan : quelle place pour les inhibiteurs de la DPP-4 ?. Médecine des Maladies Métaboliques 8:3, pages 299-305.
Crossref
Serge Halimi, Marc Levy, Dominique Huet, Stéphane Quéré & Sylvie Dejager. (2013) Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study. Diabetes Therapy 4:2, pages 385-398.
Crossref
M. Al‐Arouj, A. A. K. Hassoun, R. Medlej, M. F. Pathan, I. Shaltout, M. S. Chawla, S. Hristoskova, S. DiTommaso & M. Y. Kadwa. (2013) The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study . International Journal of Clinical Practice 67:10, pages 957-963.
Crossref
P. Hamet. (2012) What matters in ADVANCE and ADVANCE-ON. Diabetes, Obesity and Metabolism 14, pages 20-29.
Crossref
S. Al Sifri, A. Basiounny, A. Echtay, M. Al Omari, I. Harman‐Boehm, G. Kaddaha, K. Al Tayeb, A. S. Mahfouz, A. Al Elq, L. Radican, C. Özesen, H. L. Katzeff, B. J. Musser, S. Suryawanshi, C. J. Girman, M. J. Davies & S. S. Engel. (2011) The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial. International Journal of Clinical Practice 65:11, pages 1132-1140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.